Feedback / Questions
RMC-5552 - Revolution Medicines
daraxonrasib (RMC-6236) - Revolution Medicines
ulixertinib (BVD-523) - BioMed Valley Discoveries
fulvestrant - Generic mfg.
https://www.abstractsonline.com/pp8/#!/21436/presentation/11436
Priya S. Hibshman1; Dan Ye1; Rosario Chica-Parrado2; Saurabh Mendiratta1; Albert Lin1; Ariella B. Hanker1; Carlos L. Arteaga1
Mar 18, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next